Cipla Limited (BOM:500087)

India flag India · Delayed Price · Currency is INR
1,521.20
+13.10 (0.87%)
At close: Dec 4, 2025
1.34%
Market Cap 1.23T
Revenue (ttm) 279.66B
Net Income (ttm) 54.41B
Shares Out n/a
EPS (ttm) 67.32
PE Ratio 22.58
Forward PE 24.50
Dividend 16.00 (1.05%)
Ex-Dividend Date Jun 27, 2025
Volume 82,472
Average Volume 45,944
Open 1,502.40
Previous Close 1,508.10
Day's Range 1,502.40 - 1,526.00
52-Week Range 1,310.05 - 1,672.20
Beta n/a
RSI 47.93
Earnings Date Oct 30, 2025

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe... [Read more]

Industry Pharmaceutical Preparations
Founded 1935
Employees 30,313
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500087
Full Company Profile

Financial Performance

In 2024, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.

Financial Statements

News

There is no news available yet.